Suppliers / Pharma Nobis

Pharma Nobis

United States 100 employees Updated 9 July 2026

Pharma Nobis is a contract manufacturer based in United States. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 25 July 2025 as VAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 25 July 2025 VAI US FDA
  • 13 March 2020 OAI US FDA
  • 7 August 2018 NAI US FDA
  • 1 July 2015 OAI US FDA
  • 24 July 2013 VAI US FDA
  • 16 March 2012 OAI US FDA
  • 29 April 2011 VAI US FDA
  • 26 March 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Texarkana, United States 1611206

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Pharma Nobis

Is Pharma Nobis FDA-registered?
One site operated by Pharma Nobis carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Pharma Nobis's last inspection go?
The most recent inspection on record closed on 25 July 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file, of which 3 closed as OAI.
Where does Pharma Nobis manufacture?
1 registered site is on record, in United States (Texarkana). Every site is listed on this page with the register it came from.
Which regulators recognise Pharma Nobis's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Pharma Nobis comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 25 July 2025.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates